Pediatric-Inspired Chemotherapy May Benefit Adults with Leukemia

by: cancercompass

A new research study published in the Journal of Clinical Oncology suggests adult patients diagnosed with acute lymphoblastic leukemia (ALL) may benefit from pediatric chemotherapy regimes.

Researchers conducted the study to test pediatric-inspired treatments, such as increased doses of the drugs prednisone and vincristine, in adults age 60 or younger with ALL.  A total of 225 adult patients ranging in ages from 15 to 60 were enrolled in the study.

Findings showed a complete remission rate of 93.5%. At 42 months event free and overall survival rates were, respectively, at 55 and 60%. Researchers also determined 45 was the cut-off age for effectiveness of the pediatric-inspired ALL treatments.

Research to help ALL patients happens across the country through clinical trials. Learn more about leukemia treatments and talk with survivors, current patients and caregivers.